In the era of digitalisation and biosignatures, is C-reactive protein still the one to beat? - Authors' reply
- PMID: 39332850
- DOI: 10.1016/S2589-7500(24)00178-X
In the era of digitalisation and biosignatures, is C-reactive protein still the one to beat? - Authors' reply
Conflict of interest statement
All authors have filed a patent application for the six-protein signature discussed here.
Comment on
-
In the era of digitalisation and biosignatures, is C-reactive protein still the one to beat?Lancet Digit Health. 2024 Oct;6(10):e677. doi: 10.1016/S2589-7500(24)00177-8. Lancet Digit Health. 2024. PMID: 39332849 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials